LACTOSEPharmaceuticals
Lactose India Ltd — PE Ratio & Valuation Analysis
₹80.41
-7.75%
Current P/E34.23xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E39.8x14.0% below avg
⚠️
7.7% Premium to Industry
LACTOSE P/E 34.23x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2024 | ₹5.39 | ₹215 | 39.8x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Lactose India Ltd Valuation
Lactose India Ltd (LACTOSE) currently trades at 34.23x earnings. The Pharmaceuticals sector average PE is 31.77x. LACTOSE commands a premium, reflecting high growth expectations. Historically, LACTOSE has traded at an average PE of 39.8x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
9.69%
Dividend Yield
0.00%
More on Lactose India Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.